Investigating autoantibodies related to muscle repair in myositis
Autoantibodies to membrane repair proteins in myositis
This study is looking at how certain proteins that help repair muscle cells might affect the muscle weakness and inflammation seen in idiopathic inflammatory myopathies, with the hope of finding better treatments for people dealing with these challenging conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10945787 on NIH RePORTER |
What this research studies
This research focuses on idiopathic inflammatory myopathies (IIM), a group of disorders that cause muscle weakness and inflammation. The study aims to understand the role of autoantibodies to membrane repair proteins in the progression of myositis. By using advanced animal models, researchers will explore how defects in muscle cell membrane repair contribute to muscle inflammation and injury. The findings could lead to better-targeted treatments for patients suffering from these debilitating conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with idiopathic inflammatory myopathies who experience muscle weakness and inflammation.
Not a fit: Patients with myositis who do not have detectable autoantibodies or those with other unrelated muscle disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients with myositis, potentially reducing muscle inflammation and enhancing recovery.
How similar studies have performed: Previous studies have shown promising results in understanding the role of membrane repair in muscle diseases, indicating that this approach may yield valuable insights.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Jarjour, Wael N — Ohio State University
- Study coordinator: Jarjour, Wael N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.